Open access · OA
via Europe PMC
PAI-1 is a common driver of aging and diverse diseases.
Khoddam A, Miyata T, Vaughan D.
Biomedical journal · 2026 · ▲ 5 citations
Abstract
Plasminogen activator inhibitor-1 (PAI-1) is a key driver of aging and contributes to diverse pathologies. This review examines PAI-1's multifaceted contributions to aging. At the cellular level, PAI-1 amplifies senescence(definition), exhausts stem cell niches, and disrupts metabolism. These cellular alterations translate into physiological decline: PAI-1 drives cardiovascular aging by promoting vascular senescence and arterial stiffening, contributes to cognitive decline by impairing amyloid-beta clearance, fuels cancer progression through angiogenesis and immune suppression, and exacerbates muscle atrophy by hindering regeneration. A rare loss-of-function SERPINE1 mutation extends lifespan, illustrating how lifelong PAI-1 reduction can positively impact the human healthspan(definition). Looking forward, targeting PAI-1 with inhibitors could mitigate senescence, restore stem cell function, improve metabolic profile, enhance physiological health, and promise a longer healthspan.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.bj.2025.100892
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
A, K., T, M., & D., V. (2026). PAI-1 is a common driver of aging and diverse diseases. <em>Biomedical journal</em>. https://doi.org/10.1016/j.bj.2025.100892
Vancouver
A K, T M, D. V. PAI-1 is a common driver of aging and diverse diseases. Biomedical journal. 2026. doi:10.1016/j.bj.2025.100892.
BibTeX
@article{khoddam2026PAIisa,
title = {PAI-1 is a common driver of aging and diverse diseases.},
author = {Khoddam A and Miyata T and Vaughan D.},
journal = {Biomedical journal},
year = {2026},
doi = {10.1016/j.bj.2025.100892},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Investigation 2018
Open access · OA
Role of sphingolipids in senescence: implication in aging and age-related diseases
Nature Communications 2025
Open access · CC-BY
High-content screening identifies ganoderic acid A as a senotherapeutic to prevent cellular senescence and extend healthspan in preclinical models
International Journal of Molecular Sciences 2023
Open access · CC-BY
Vitamin D as a Shield against Aging
Central Asian Journal of Medical Hypotheses and Ethics 2026
Open access · CC-BY
STEM CELL REJUVENATION: MECHANISMS, MODALITIES, AND TRANSLATIONAL CHALLENGES IN REGENERATIVE ANTI-AGING MEDICINE
Aging and Disease 2023
Open access · CC-BY
Aging, Cellular Senescence, and Glaucoma
Aging and Disease 2024
Open access · CC-BY